Steven Cohen Abiomed Inc Transaction History

Point72 Asset Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$224.73 - $338.64 $8.07 Million - $12.2 Million	-35,901 Reduced 39.93%	53,999 $13.4 Million
Q1 2022 May 16, 2022	BUY	$277.25 - $366.29 $24.9 Million - $32.9 Million	89,900 New	89,900 $29.8 Million
Q3 2019 Nov 15, 2019	SELL	$175.89 - $279.23 $322,582 - $512,107	-1,834 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$250.96 - $284.94 $7.02 Million - $7.97 Million	-27,960 Reduced 93.84%	1,834 $478,000
Q1 2019 May 15, 2019	BUY	$276.39 - $362.25 $8.23 Million - $10.8 Million	29,794 New	29,794 $8.51 Million

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.